Author Search Results

1

P20-20 LB. Indels in V4 share sequence features with insertions and deletions during somatic hypermutation of immunoglobulins

by Graziosi C, Pantaleo G, Guglietta S
Published 2009-10-01

Article

2

P16-32. Antigen exposure regulates the balance between proliferating and cytotoxic subsets of virus-specific CD8 T-cells

by Harari A, Pantaleo G, Bart P, Enders F, Rozot V, Perreau M, Cellerai C
Published 2009-10-01

Article

3

P16-48. Immunologic and virologic characterization of an ART-treated HIV-1 patients cohort with long-term control of viremia

by Harari A, Johnson A, Stauss H, Carroll A, Byrne P, Yerly S, Cellerai C, Kinloch S, Pantaleo G
Published 2009-10-01

Article

4

OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines

by Parrington M, Arndt W, Denzler K, Holechek S, Huynh T, Wong S, Kibler K, Jacobs B, Tartaglia J, Pantaleo G
Published 2009-10-01

Article

5

rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses

by Bart P, Huang Y, Frahm N, Karuna S, Allen M, Kochar NK, Chappuis S, Gaillard J, Graham B, Pantaleo G
Published 2012-09-01

Article

6

rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1

by Montefiori DC, Huang Y, Karuna S, Allen M, Kochar N, Chappuis S, Gaillard J, Tomaras G, Graham B, Bart P, Pantaleo G
Published 2012-09-01

Article

7

P17-23. Enhanced expression of HIV antigens and improved antigen presentation after infection with replication competent attenuated vaccinia virus <it>in vitro</it>

by Jacobs B, Kibler K, Esteban M, Nieto J, Heinen P, Perdiguero B, Loof N, Redeker A, Quakkelaar E, Pantaleo G, Melief C
Published 2009-10-01

Article

8

Comparison of the depth of vaccine-elicited HIV-1 Env epitope-specific CD8+ T lymphocyte responses

by Hulot SL, Korber BT, Pantaleo G, Tartaglia J, Jacobs B, Perdiguero B, Gomez CE, Esteban M, Letvin N, Seaman MS, Haynes B, Santra S
Published 2012-09-01

Article

9

Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C

by Gómez C, Perdiguero B, Jimenez V, Filali-Mouhim A, Ghneim K, Haddad E, Quakkerlaar E, Delaloye J, Harari A, Roger T, Duhem T, Sekaly R, Melief C, Calandra T, Sallusto F, Lanzavecchia A, Wagner R, Pantaleo G, Esteban M
Published 2012-09-01

Article

10

Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine

by Ellefsen-Lavoie K, Rockstroh J, Pollard R, Pantaleo G, Podzamczer D, Asmuth D, van Lunzen J, Arastéh K, Schürmann D, Peters B, Clotet B, Hardy D, Lazzarin A, Gatell J, Sommerfelt MA, Baksaas I, Wendel-Hansen V, Sørensen B
Published 2012-09-01

Article

11

Assessing the drivers of syphilis among men who have sex with men in Switzerland reveals a key impact of screening frequency: A modelling study

by Anagnostopoulos, A., Balakrishna, S., Battegay, M., Battegay, M., Bernasconi, E., Bernasconi, E., Böni, J., Braun, D.L, Bucher, H.C, Calmy, A., Cavassini, M., Cavassini, M., Ciuffi, A., Dollenmaier, G., Egger, M., Elzi, L., Fehr, J., Fellay, J., Furrer, H., Fux, C.A, Günthard, H., Günthard, H.F, Haerry, D., Hasse, B., Hirsch, H.H, Hoffmann, M., Hösli, I., Huber, M., Kachalov, V., Kahlert, C.R, Kaiser, L., Keiser, O., Klimkait, T., Kouyos, R.D, Kouyos, R.D, Kovari, H., Kusejko, K., Ledergerber, B., Martinetti, G., Martinez de Tejada, B., Marzolini, C., Metzner, K.J, Müller, N., Nicca, D., Nicca, D., Paioni, P., Pantaleo, G., Perreau, M., Rauch, A., Rauch, A., Roth, J.A, Rudin, C., Salazar-Vizcaya, L., Scherrer, A.U, Schmid, P., Schmid, P., Schmidt, A.J, Speck, R., Stöckle, M., Tarr, P., the Swiss HIV Cohort Study (SHCS), Thurnheer, M.C, Trkola, A., Vernazza, P., Wandeler, G., Weber, R., Yerly, S.
Published 2021

View Fulltext in Publisher

Article

Related Subjects